Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs. Natalie Rahhal. July 2, 2025 at 7:00 AM. Copied; ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

Tirzepatide was first approved for use in the US in May 2022, when it received an indication for adult patients with type 2 diabetes. 1 Indications for chronic weight management and sleep apnea ...